The 77 rating InvestorsObserver gives to Sorrento Therapeutics Inc (SRNE) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 94 percent of stocks in the Biotechnology industry, SRNE’s 77 overall rating means the stock scores better than 77 percent of all stocks.
Click Here to get the full Stock Score Report on Sorrento Therapeutics Inc (SRNE) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 77 means the stock is more attractive than 77 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Sorrento Therapeutics Inc Stock Today?
Sorrento Therapeutics Inc (SRNE) stock has fallen -2.56% while the S&P 500 is up 0.19% as of 9:56 AM on Wednesday, Jan 29. SRNE is down -$0.11 from the previous closing price of $4.05 on volume of 1,518,660 shares. Over the past year the S&P 500 has risen 24.33% while SRNE is up 88.52%. SRNE lost -$2.25 per share the over the last 12 months.
